Founded in 2009, Boston Biodevelopment is a premium regulatory strategy consulting firm specializing in the development and approval of innovative therapies. Our team of highly experienced regulatory professionals, including former Heads of Regulatory Affairs, provides hands-on strategic leadership and execution across all stages of the product lifecycle.

Our signature services include Interim Head of Regulatory Affairs Leadership and Embedded Regulatory Teams, providing clients with experienced regulatory leaders and functional experts who integrate seamlessly within their organizations. Whether augmenting existing capabilities or serving as a fully embedded regulatory function, our consultants deliver strategic continuity, operational excellence, and immediate impact.

We bring deep expertise across biologics, small molecules, cell and gene therapies, gene editing, and other advanced modalities, with extensive experience in rare diseases and a broad range of therapeutic areas. Clients rely on Boston Biodevelopment to accelerate development programs, navigate complex regulatory challenges, and bring innovative therapies to patients with confidence.